Exosomal microRNAs in Periodontitis: From Molecular Footprints to Clinical Frontiers

Maaz Anwer Memon1,2, Danial Qasim Butt2, Noriko Mizusawa3

  • 1School of Dental Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian, Kelantan 16150, Malaysia.

Insights

Exosomes carrying microRNAs (miRNAs) are key in periodontitis, influencing inflammation and bone loss. This review links their molecular roles to clinical potential for diagnostics and therapies.

Area of Science:

  • Periodontology
  • Molecular Biology
  • Immunology

Background:

  • Periodontitis is a chronic inflammatory disease causing bone loss and systemic issues.
  • Exosomes and their microRNAs (miRNAs) are crucial in periodontal intercellular communication, inflammation, and immunity.
  • A comprehensive framework linking exosomal miRNA mechanisms to clinical applications in periodontitis is needed.

Purpose of the Study:

  • To propose an integrative framework for exosomal miRNAs in periodontitis, from biogenesis to clinical relevance.
  • To analyze the roles of specific exosomal miRNAs (e.g., miR-146a, miR-155, miR-223) as biomarkers and regulators.
  • To evaluate advanced analytical methods and translational applications of exosomal miRNAs in periodontology.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of molecular mechanisms of exosomal miRNA biogenesis and function.
  • Examination of systems biology, multiomics, and network modeling approaches.
  • Evaluation of diagnostic and therapeutic applications and translational challenges.

Main Results:

  • Exosomal miRNAs, particularly miR-146a, miR-155, and miR-223, play dynamic roles in periodontal inflammation and tissue remodeling.
  • Advanced analytical techniques like multiomics integration can enhance mechanistic understanding and predictive accuracy.
  • Emerging applications include noninvasive biomarker development and targeted regenerative therapies.

Conclusions:

  • Exosomal miRNAs hold significant potential for advancing precision diagnostics and targeted therapeutics in periodontitis.
  • Future research should focus on engineered exosomes for drug delivery and exosomal miRNA biosensors for monitoring.
  • Overcoming translational challenges like standardization and in vivo validation is crucial for clinical implementation.

Related Concept Videos

The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...